“First-of-its-kind collaboration”

AstraZeneca (AZN) and Vanguard Renewables have announced a partnership to enable the delivery of renewable natural gas (RNG) to all of AZN’s US sites by the end of 2026. Neil H. Smith, Vanguard Renewables’ CEO, tells Bioenergy Insight more.
From June this year, AZN began purchasing RNG produced by Vanguard Renewables for its Newark Campus in Delaware, where the company packages 26 medicines for distribution across the US and makes medicine formulations for global supply.
By 2026, this collaboration is set to enable as much as 650,000 million British thermal units (MMBtu), or 190,500 megawatt hours (MWh), per year of RNG to be used across AstraZeneca’s US sites, equivalent to the energy required to heat more than 17,800 US homes for a year.
Origins
The partnership between the two companies came about because the companies’ respective industries — food & beverage and dairy farming; and pharmaceuticals — have a shared goal of decarbonisation, according to Smith.
“AstraZeneca has set very aggressive sustainability goals and is doing the hard work to achieve them,” noted Smith. “Pascal Soriot, their...